Literature DB >> 23017429

Melatonin receptor agonists for treating delirium in elderly patients with acute stroke.

Tsuyoshi Ohta1, Kenichi Murao, Kosuke Miyake, Koichiro Takemoto.   

Abstract

BACKGROUND: Delirium is considered to worsen life prognosis in elderly patients with stroke. We examined the effects of the melatonin receptor agonist ramelteon for treating delirium in elderly stroke patients with insomnia in comparison to the other drugs.
METHODS: Elderly patients with delirium and insomnia after acute stroke who were treated with ramelteon (7 patients; mean age 76 years) and the other drugs (21 patients; mean age 77.3 years) between July 2011 and March 2012 at our hospital were retrospectively examined.
RESULTS: All patients treated with ramelteon had a significant improvement within a week and were started on early and aggressive rehabilitation. No patient experienced oversedation, neurologic deterioration, or any other worsening effect associated with ramelteon treatment.
CONCLUSIONS: Melatonin receptor agonists may be effective for the treatment of delirium in elderly patients with acute stroke.
Copyright © 2013 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute stroke; delirium; elderly individuals

Mesh:

Substances:

Year:  2012        PMID: 23017429     DOI: 10.1016/j.jstrokecerebrovasdis.2012.08.012

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  6 in total

1.  Exogenous Melatonin for Delirium Prevention: a Meta-analysis of Randomized Controlled Trials.

Authors:  Sheng Chen; LiGen Shi; Feng Liang; Liang Xu; Doycheva Desislava; Qun Wu; Jianmin Zhang
Journal:  Mol Neurobiol       Date:  2015-07-21       Impact factor: 5.590

2.  Pharmacological interventions for the treatment of delirium in critically ill adults.

Authors:  Lisa Burry; Brian Hutton; David R Williamson; Sangeeta Mehta; Neill Kj Adhikari; Wei Cheng; E Wesley Ely; Ingrid Egerod; Dean A Fergusson; Louise Rose
Journal:  Cochrane Database Syst Rev       Date:  2019-09-03

3.  Delirium: ramelton.

Authors:  Joyce A Generali; Dennis J Cada
Journal:  Hosp Pharm       Date:  2013-04

Review 4.  Melatonergic drugs in development.

Authors:  Alessia Carocci; Alessia Catalano; Maria Stefania Sinicropi
Journal:  Clin Pharmacol       Date:  2014-09-18

5.  Preventive effect of ramelteon on emergence agitation after general anaesthesia in paediatric patients undergoing tonsillectomy: a randomised, placebo-controlled clinical trial.

Authors:  Maya Komazaki; Takahiro Mihara; Nobuhito Nakamura; Koui Ka; Takahisa Goto
Journal:  Sci Rep       Date:  2020-12-15       Impact factor: 4.379

6.  Melatonin and the Prevention and Management of Delirium: A Scoping Study.

Authors:  Sin Wei Choy; Aun Chian Yeoh; Zhao Zheng Lee; Velandai Srikanth; Chris Moran
Journal:  Front Med (Lausanne)       Date:  2018-01-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.